Akanksha Gupta

A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis

James G. Krueger, Mayte Suárez‐Fariñas, Inna Cueto et al. · PLoS ONE · 2015 · 103 citations · Full text

Medicine, Dermatology, Immunology +17

Scaling Up Diarrhea Prevention and Treatment Interventions: A Lives Saved Tool Analysis

Christa L. Fischer Walker, Ingrid K. Friberg, Nancy Binkin et al. · PLoS Medicine · 2011 · 88 citations · Full text

Public Health, Child Health, Preventive Medicine +17

Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes

Jennifer L. Aponte, Mathias Chiano, Laura M. Yerges-Armstrong et al. · Human Molecular Genetics · 2018 · 50 citations · Full text

Life Sciences, Dermatology, Genetics +15

Phenome-wide association study using research participants’ self-reported data provides insight into the Th17 and IL-17 pathway

Margaret G. Ehm, Jennifer L. Aponte, Mathias Chiano et al. · PLoS ONE · 2017 · 22 citations · Full text

Life Sciences, Genetics, Immunology +17

The Identification of the SIRT1 Activator SRT2104 as a Clinical Candidate

Pui Yee Ng, Jean E. Bemis, Jeremy S. Disch et al. · Letters in Drug Design & Discovery · 2013 · 18 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12